Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy - Liu, Qiang; Guan, Yujing; Li, Shenglong (Molecular cancer, 2024)
Keywords: Animals; B7-H1 Antigen - metabolism; Combination therapy; Humans; Immune Checkpoint Inhibitors - pharmacology; Immune Checkpoint Inhibitors - therapeutic use; Immunotherapy - methods; PD-1; PD-L1; Programmed Cell Death 1 Receptor - metabolism; Regulatory mechanism; Review; Signal Transduction - drug effects; Tumor Escape; Tumor immunity; Urologic Neoplasms - drug therapy; Urologic Neoplasms - etiology; Urologic Neoplasms - immunology; Urologic Neoplasms - metabolism; Urologic Neoplasms - pathology; Urologic Neoplasms - therapy; PD-L1; Tumor immunity; Combination therapy; PD-1; Regulatory mechanism